RAYMOND JAMES & ASSOCIATES - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$374,868
-14.8%
13,350
-14.1%
0.00%
Q3 2022$440,00015,5490.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 965,369$56,378,00014.98%
Casdin Capital, LLC 237,500$13,870,0008.18%
BB BIOTECH AG 2,839,528$165,828,0005.42%
Opaleye Management Inc. 130,000$7,592,0003.78%
Redmile Group, LLC 902,578$52,711,0003.42%
Clarius Group, LLC 109,230$6,379,0002.63%
Opus Point Partners Management, LLC 57,410$3,353,0002.49%
Ghost Tree Capital, LLC 125,000$7,300,0001.36%
CAPITAL INTERNATIONAL LTD /CA/ 346,937$20,261,0001.32%
Eventide Asset Management 300,800$17,567,0001.16%
View complete list of AGIOS PHARMACEUTICALS INC shareholders